Fibrocell Science Inc (NASDAQ:FCSC)

Data as of 10:41am ET
 -0.06 / -2.13%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Fibrocell Science, Inc. develops autologous cellular system. It a commercial-stage, autologous cellular therapeutic company focused on the development of products for aesthetic, medical and scientific applications. The company has a pipeline of therapeutic and aesthetic product development programs based on the first Food and Drug Administration approved cell-based product, LAVIV™ (azficel-T), in aesthetics, all of which are based on the autologous fibroblast cell. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. Fibrocell Science was founded on September 1, 2009 and is headquartered in Exton, PA.

Contact Information

Fibrocell Science, Inc.
405 Eagleview Boulevard
Exton Pennsylvania 19341
P:(484) 713-6000
Investor Relations:



Individual stakeholders38.43%
Other institutional17.34%
Mutual fund holders10.06%

Top Executives

David M. PernockChairman, President & Chief Executive Officer
Gregory L. WeaverCFO, Secretary, Treasurer & Senior Vice President
John MaslowskiVice President-Scientific Affairs
Laura CampbellVice President-Planning
Robert James SheroffVice President-Technical Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.